>
Switch to:

Travere Therapeutics EV-to-Revenue

: 7.95 (As of Today)
View and export this data going back to 2003. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Travere Therapeutics's enterprise value is $1,541.6 Mil. Travere Therapeutics's Revenue for the trailing twelve months (TTM) ended in Sep. 2020 was $194.0 Mil. Therefore, Travere Therapeutics's EV-to-Revenue for today is 7.95.

NAS:TVTX' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.6   Med: 4.5   Max: 17396.7
Current: 7.95

1.6
17396.7

During the past 9 years, the highest EV-to-Revenue of Travere Therapeutics was 17396.70. The lowest was 1.60. And the median was 4.50.

NAS:TVTX's EV-to-Revenue is ranked higher than
73% of the 914 Companies
in the Biotechnology industry.

( Industry Median: 24.02 vs. NAS:TVTX: 7.95 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2021-02-25), Travere Therapeutics's stock price is $29.950000. Travere Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was $4.27. Therefore, Travere Therapeutics's PS Ratio for today is 7.02.


Travere Therapeutics EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Travere Therapeutics Annual Data
Feb11 Feb12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.18 3.79 3.71 4.16 2.39

Travere Therapeutics Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.70 2.39 2.62 4.23 3.59

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Travere Therapeutics EV-to-Revenue Distribution

* The bar in red indicates where Travere Therapeutics's EV-to-Revenue falls into.



Travere Therapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Travere Therapeutics's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1541.634/194.025
=7.95

Travere Therapeutics's current Enterprise Value is $1,541.6 Mil.
Travere Therapeutics's Revenue for the trailing twelve months (TTM) ended in Sep. 2020 was 46.687 (Dec. 2019 ) + 47.769 (Mar. 2020 ) + 48.43 (Jun. 2020 ) + 51.139 (Sep. 2020 ) = $194.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Travere Therapeutics  (NAS:TVTX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Travere Therapeutics's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=29.950000/4.267
=7.02

Travere Therapeutics's share price for today is $29.950000.
Travere Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2020 was 1.085 (Dec. 2019 ) + 1.096 (Mar. 2020 ) + 1.082 (Jun. 2020 ) + 1.004 (Sep. 2020 ) = $4.27.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Travere Therapeutics EV-to-Revenue Related Terms


Travere Therapeutics EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)